Elixirgen Therapeutics
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 N Wolfe St Ste 62, Baltimore, Maryla...Phone Number
(443) 869-5420Revenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elixirgen Therapeutics
Based in Baltimore, Elixirgen Therapeutics, Inc. is a biotechnology company, which is focused on curing humanity's ailments through innovations in gene and cell therapy, including stem cell therapy.Explore more
Elixirgen Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elixirgen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Elixirgen Therapeutics launches new products
Earning: See what the market has to say on Elixirgen Therapeutics recently announced quarterly report
Check out if Elixirgen Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Elixirgen Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Elixirgen Therapeutics has new funding data
Check if Elixirgen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Elixirgen Therapeutics had a recent Job posting/layoffs
Elixirgen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Elixirgen Therapeutics
Compare insights from companies similar to Elixirgen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elixirgen Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Elixirgen Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Elixirgen Therapeutics.
Elixirgen Therapeutics financials insights
Gather financial insights about Elixirgen Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$4.2M
Elixirgen Therapeutics Tech Stack
A closer look at the technologies used by Elixirgen Therapeutics
Elixirgen Therapeutics News & Media
Elixirgen Therapeutics Enters Memorandum of Understanding with Hitachi Global Life Solutions for the Development of Micro GMP Suites for Cell Therapy Administration
BALTIMORE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self-replicating RNA (c-srRNA) platform, today announced that it has entered a memorandum of understanding with Hitachi Global Life Solutions, Inc. (Hitachi GLS) for the development of Micro GMP suites to facilitate cell therapy administration.Elixirgen Therapeutics to Attend the 2023 Biotech Showcase Conference
BALTIMORE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self-replicating RNA (c-srRNA) platform, today announced that members of the management team will be attending the Biotech Showcase Conference taking place January 9-11, 2023 in San Francisco, California. Akihiro Ko, chief executive officer, and Moriah Nachbaur, chief business officer, wilElixirgen Therapeutics Appoints Jeffrey L. Cleland, Ph.D., to Board of Directors
BALTIMORE, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self-replicating RNA (c-srRNA) platform, today announced the appointment of Jeffrey L. Cleland, Ph.D., to the Board of Directors to support the advancement of its technology in developing therapies for a broad spectrum of diseases including rare diseases, aging-related disorders and cancerElixirgen Therapeutics Presents New Clinical Data Demonstrating Ex Vivo Telomere Elongation with EXG-34217 in Dyskeratosis Congenita at the 64th ASH Annual Meeting
BALTIMORE, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies using its controllable self-replicating RNA (c-srRNA) platform, today announced new data from a Phase 1/2 trial (NCT04211714) showing successful ex vivo telomere elongation with lead asset, EXG-34217 (autologous CD34+ hematopoietic stem cells that have been treated ex vivo with EXG-001), in a patient with dysker
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elixirgen Therapeutics
Sign Up For FreeTo access detailed company insights
Based in Baltimore, Elixirgen Therapeutics, Inc. is a biotechnology company, which is focused on curing humanity's ailments through innovations in gene and cell therapy, including stem cell therapy.... Read More
